Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,57
KB0,19
PKN102,15102,3-3,27
Msft147,31147,320,81
Nokia3,213,2135-0,62
IBM135,82135,840,27
Daimler AG53,953,920,92
PFE37,0237,030,24
12.11.2019 19:24:39
Indexy online
AD Index online
select
AD Index online
 

  • 12.11.2019 18:00:02
YIT (YTY1V.HE, Helsinki)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
5,79 -1,03 -0,06 1 187 341
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 12.11.2019
Popis společnosti

Business Summary: Yit Oyj is a Finland-based provider of services for the real estate, construction and industry sectors. The Company operates in four segments: Housing Finland and CEE, Housing Russia, Business Premises and Infrastructure, as well as Partnership Properties. The Housing Finland and CEE comprises construction and developments of apartments and entire residential areas in Finland, Estonia, Latvia, Lithuania, the Czech Republic, Slovakia, Poland. The Housing Russia and Business Premises implies construction and development of apartments and entire residential areas, as well as service and maintenance business, in seven regions in Russia. The Business Premises and Infrastructure comprises construction of offices, shopping centers, care facilities, roads, bridges, rail and metro stations, harbors, road and street maintenance in Finland, Estonia, Latvia, Lithuania and Slovakia. The Partnership Properties focuses on ownership and creating financing structures for development projects.
Financial Summary: BRIEF: For the nine months ended 30 September 2019, YIT Oyj revenues increased 11% to EUR2.24B. Net loss applicable to common stockholders excluding extraordinary items increased from EUR5.9M to EUR55.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Housing-Finland and CEE segment income decrease of 42% to EUR43.1M.



  • Poslední aktualizace: 12.11.2019
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerMark Alles5905.02.201815.02.2012
Chief Financial Officer, Executive Vice PresidentDavid Elkins5001.08.201801.07.2018
President - Global Hematology & OncologyNadim Ahmed51
President, Global Inflammation & Immunology FranchiseTerrie Curran5001.04.201701.04.2017
President - Global Clinical DevelopmentAlise Reicin5801.11.201801.11.2018
President - Research and Early DevelopmentRupert Vessey5408.01.201608.01.2016
Executive Vice President, General CounselJonathan Biller5503.07.201803.07.2018
Executive Vice President and Chief Corporate Strategy OfficerPeter Kellogg6201.08.201801.07.2014